Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05839691 · ClinicalTrials.gov registry record
Improving the Cardiovascular Health of High-Risk Families Through an Innovative Home Visitation Intervention
A clinical trial of Health Behavior and Nutrition, Healthy, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 115
- Enrollment target
- 1
- Study location
NCT05839691: Completed study of Health Behavior and Nutrition, Healthy, sponsored by University of Alabama at Birmingham.
NCT05839691 is a study of Health Behavior and Nutrition, Healthy that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 115 participants, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05839691, a study of Health Behavior and Nutrition, Healthy, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to conduct formative work with relevant stakeholders, including families and home visitation program staff involved in previous studies and/or future projects, to understand facilitators, barriers, and other attitudes related to incorporating cardiovascular health topics into existing curricula and to obtain input on treatment modifications for future programs.
Primary Outcome
Percentage of survey respondents (out of total respondents) who self-report they are currently pregnant or gave birth within the last year. Participants will self-report by responding to a one-item, multiple choice survey question. In response, they can mark all that apply of the following: a) I am currently pregnant, b) I gave birth to a child who currently is less than 6 months old, c) I gave birth to a child who is currently between 6 months and less than 1 year old, d) I gave birth to a chil
Conditions Studied
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2023-11-30 |
What the finished NCT05839691 record still lists
NCT05839691 is an observational study that tracks outcomes without assigning an intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 2,184-participant average among 65 other Health Behavior trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Health Behavior appearing as the primary indexed condition, and to 0 interventions.
NCT05839691 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05839691 about?
NCT05839691 is a clinical study titled "Improving the Cardiovascular Health of High-Risk Families Through an Innovative Home Visitation Intervention". The purpose of this study is to conduct formative work with relevant stakeholders, including families and home visitation program staff involved in previous studies and/or future projects, to understand facilitators, barriers, and other attitudes related to incorporating cardiovascular health topics...
What is the current status of trial NCT05839691?
This trial is currently completed. The enrollment target is 115 participants. The study started on 2023-10-05. Estimated completion is 2023-11-30.
What conditions does trial NCT05839691 study?
This clinical trial studies the following conditions: Health Behavior, Nutrition, Healthy, Maternal Behavior.
Who is sponsoring clinical trial NCT05839691?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05839691 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05839691's enrollment target sits among peer trials
115 38th of 65 higher than 28 of 65 other Health Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sugary Drink Labeling Study
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
The Lake Nona Life Project
RECRUITING
-
The Validation Study of Bioelectronics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI